Abstract
Introduction. Chronic thromboembolic pulmonary hypertension (CTEPH) represents uncommon or under-diagnosed sequel of acute or chronic pulmonary embolism (PE). The gold standard therapy for CTEPH is pulmonary endarterectomy (PEA) which markedly improves the prognosis or even cures the disease in the majority of patients with CTEPH [1]. Nevertheless some CTEPH patients are not operable due to small-vessel disease (“distal CTEPH”) due to significant co-morbidities making the risk of surgery unacceptably high [2,3].
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
